Valmet announces a new strategy, 'Lead the Way', and publishes new 2030 financial targets
Valmet Oyj's stock exchange release on June 4, 2025 at 8:30 p.m. EEST
ESPOO, Finland., June 4, 2025 /PRNewswire/ -- Valmet is holding its Capital Markets Day 2025 tomorrow June 5, 2025, presenting its new strategy and 2030 financial targets designed to deliver a step-up improvement in financial performance, growth, and ability to transform industries towards a regenerative tomorrow.
"Since stepping into the role of President and CEO ten months ago, I've had the opportunity to engage deeply with our customers, employees and investors around the world. These conversations reaffirmed that Valmet's 225-year legacy, strong customer relationships, and highly committed people form a powerful foundation for the company's next chapter.
At the same time, it became clear that realizing our full potential requires a shift in mindset and culture – one that elevates performance, sharpens accountability, and unlocks new levels of value creation.
With our strategic renewal now complete, we are bringing sharper focus and higher ambition to everything we do. Our new strategy 'Lead the Way' is built on four fundamentals and a smaller number of more ambitious initiatives than before. The new operating model simplifies our structure, strengthens cost competitiveness, and reinforces accountability.
For our people, this new strategy means improved role clarity, full empowerment, and accountability. For our stakeholders, it translates to greater customer value, improved financial performance, and stronger shareholder returns," says Valmet's President and CEO Thomas Hinnerskov.
New strategy 'Lead the Way'
The new strategy is designed to create an accountable high-performance culture and accelerate the growth trajectory towards bolder targets with increased cost competitiveness.
During the strategy renewal Valmet has defined its purpose as 'Transforming industries towards a regenerative tomorrow'.
Valmet's new Strategy 'Lead the Way' is based on four strategic fundamentals:
Customer success
Lifecycle commitment
Global competitiveness
Accountability
These strategic fundamentals are being reinforced by Valmet's operating model renewal, announced on March 31, 2025, and becoming effective on July 1, 2025. The new operating model allows the company to operate with strong business areas close to customers, providing integrated expertise in services and technology. A newly formed Global Supply unit for manufacturing and procurement will centrally drive operational excellence and ensure cost competitiveness.
2030 Financial Targets
Valmet's new 2030 financial targets reflect a step change in ambition. Valmet's financial targets are the following (previous targets in brackets):
Organic net sales growth (CAGR) over the cycle of 5% (previously: over two times the market growth or exceed market growth)
Comparable EBITA margin of 15% (previously: 12–14%)
Comparable return on capital employed before taxes (Comparable ROCE) of 20% (previously: at least 15%)
Gearing below 50% (new target)
Valmet is establishing clear capital allocation priorities to support the strategy and long-term value creation.
Segment-specific strategic missions, priorities and targets
Valmet is setting two distinct strategic missions and sets of strategic priorities for two segments within the company.
Biomaterial Solutions and Services segment consists of three business areas: Pulp, Energy and Circularity; Packaging and Paper; and Tissue. Strategic mission for the segment is Advancing circularity.
Segment has three strategic priorities:
Seamless lifecycle approach to grow in services and technology
Continuous innovation with customers, leading the way towards circularity
Relentless drive for product cost competitiveness
The new Global Supply organization targets EUR 100 million of cost efficiencies by optimizing procurement, logistics, and manufacturing activities across the full Biomaterial Solutions and Services segment.By 2030, the segment seeks to double the organic growth in biomaterial services to 8% and reach 14% Comparable EBITA margin (LTM Q1 2025: 10.5%). Process Performance Solutions segment consists of two business areas: Automation Solutions and Flow Control. Strategic mission for the segment is Unlocking resource efficiency.
Segment has three strategic priorities:
Leading lifecycle value, reliability and customer experience
Customer-focused innovation and strategic portfolio expansion
Growth in high-quality technologies and digital capabilities in mission-critical solutions
By 2030, the segment seeks to accelerate organic growth to over double the market rate and reach 20% Comparable EBITA margin (LTM Q1 2025: 17.6%).
Guidance for 2025 unchanged
Valmet reiterates its guidance issued on February 13, 2025, in which Valmet estimates that net sales in 2025 will remain at the previous year's level in comparison with 2024 (EUR 5,359 million) and Comparable EBITA in 2025 will remain at the previous year's level in comparison with 2024 (EUR 609 million).
Capital Markets Day on June 5, 2025
To present the new strategy in more detail and answer questions, Valmet will host its 2025 Capital Markets Day tomorrow. The event can be followed via a live webcast at https://valmet.videosync.fi/cmd-2025. The webcast will run from 12:00 to 3:00 p.m. EEST. A recording of the event will be available at the same address shortly after the event.
Presentation materials will be available on Valmet's CMD 2025 website by the beginning of the event. The language of the event and materials is English.
Further information about Valmet's Capital Markets Day, please contact:Investors and analysts: Pekka Rouhiainen, VP, Investor Relations, Valmet, tel. +358 10 672 0020Media: Antti Ylitalo, Director, External Communications, Valmet, tel. +358 10 672 0000
VALMET Katri HokkanenCFOPekka RouhiainenVP, Investor Relations
DISTRIBUTION:Nasdaq HelsinkiMajor mediawww.valmet.com
Valmet has a global customer base across various process industries. We are a leading global developer and supplier of process technologies, automation and services for the pulp, paper and energy industries, and with our automation and flow control solutions we serve an even wider base of process industries. Our more than 19,000 professionals around the world work close to our customers and are committed to moving our customers' performance forward – every day.
The company has more than 225 years of industrial history and a strong track record in continuous improvement and renewal. Valmet's net sales in 2024 were approximately EUR 5.4 billion.
Valmet's shares are listed on the Nasdaq Helsinki and the head office is in Espoo, Finland.
Follow us on valmet.com | X | X (IR) | LinkedIn | Facebook | YouTube | Instagram |
Processing of personal data
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/valmet-oyj/r/valmet-announces-a-new-strategy---lead-the-way--and-publishes-new-2030-financial-targets,c4159385
View original content:https://www.prnewswire.co.uk/news-releases/valmet-announces-a-new-strategy-lead-the-way-and-publishes-new-2030-financial-targets-302473550.html
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Japanese AI Unicorn Notta Enters Otter AI's Market with Innovative Smart Voice Recorder
Notta Bets Big on AI Agent-Powered Voice Recorder as Hardware-SaaS Convergence Accelerates TOKYO, June 6, 2025 /PRNewswire/ -- As OpenAI's ChatGPT dominates enterprise AI adoption and Google Gemini reshapes how businesses think about AI assistants, Japanese unicorn Notta announced its ambitious push into the U.S. hardware market with the Notta Memo AI Voice Recorder. From Tokyo to Silicon Valley: The Underdog Story Notta's journey reads like a classic tech disruption playbook, albeit with a Japanese twist. Since launching in 2020, the company has quietly built a formidable AI transcription empire, amassing over 10 million users globally and signing up 4,000 enterprise customers. The real validation? A staggering 68% of Japan's Nikkei 225 companies—the country's most elite corporations—have integrated Notta's AI solutions into their workflows. "Most observers underestimate just how competitive the Japanese enterprise market is," explains industry analyst Sarah from TechInsight Research. "If you can win over two-thirds of the Nikkei 225, you've proven enterprise-grade reliability at scale." Notta's 2022 Airgram acquisition was just the opening move—the company believes the real opportunity lies in completely reimagining how voice technology integrates into daily workflows. Security-First Approach Gives Notta Enterprise Edge Unlike many AI startups that retrofit compliance as an afterthought, Notta built enterprise security into its foundation from day one. The company holds ISO/IEC 27001 and SOC 2 Type II certifications—credentials that remain elusive for many competitors still scrambling to meet Fortune 500 requirements. More critically, Notta has secured the regulatory trifecta that unlocks major markets: GDPR compliance for European expansion, HIPAA certification for healthcare disruption, and CCPA adherence for California's privacy-conscious landscape. This compliance-first strategy positions Notta to compete for high-value enterprise contracts that security-conscious organizations won't trust to less mature platforms. Hardware Meets AI: The Five-Platform Ecosystem Play The Notta Memo distinguishes itself in the crowded voice recording market through its unique five-platform ecosystem integration—seamlessly connecting web, iOS, Android, Chrome extension, and the Memo device itself. This comprehensive approach addresses the fragmented user experience that has long plagued the industry. Unlike traditional voice recording solutions that force users to choose between SaaS flexibility and hardware reliability, Notta Memo delivers both. The device features advanced bone-conduction technology for complete phone call recording, intelligent noise reduction for crystal-clear audio capture, and one-tap synchronization with Notta. "We're not just launching another recording device," said Ryan, CEO of Notta. "We're introducing a complete AI-powered voice ecosystem that adapts to how people work and communicate in today's hybrid world. Our hardware becomes an extension of our proven AI platform that has already transformed millions of meetings worldwide." Beyond recording, Notta Memo is your AI-powered agent and centralized knowledge hub—seamlessly integrated across all your workflows. Competitive Positioning in a Dynamic Market Notta enters the US AI transcription market with an integrated approach that combines software and hardware innovation. While the market includes established players like Otter AI in the SaaS space and Plaud AI in hardware solutions, Notta differentiates itself through its comprehensive platform that leverages AI capabilities refined through years of serving millions of global users. The company acknowledges the challenges in competing against established players with loyal American user bases. However, Notta's proven track record of rapid user acquisition and revenue growth in Japan, combined with its technological differentiation, positions it as a formidable new entrant. Market Timing and Strategic Vision Notta's American expansion comes at a pivotal moment in the AI industry. As enterprises increasingly adopt AI agents for productivity enhancement and consumers demand more intelligent, seamless technology experiences, the convergence of AI SaaS and purpose-built hardware represents a natural evolution. The Notta Memo's launch signals more than just product diversification – it represents Notta's vision of AI-native hardware that thinks, learns, and adapts to user needs. This positions the company at the forefront of the next wave of AI innovation, where the distinction between SaaS and hardware dissolves into unified, intelligent experiences. About Notta Notta is the AI unicorn that's redefining how the world captures and understands conversations. Seamlessly integrating advanced SaaS with intelligent hardware, Notta turns conversations from any meeting, call, or discussion into actionable insights. This AI-powered, end-to-end solution captures and structures spoken interactions, creating a centralized knowledge hub. Media Contact: contact@ View original content to download multimedia: SOURCE Notta
Yahoo
4 hours ago
- Yahoo
The Coffee Bean & Tea Leaf® Kicks Off Summer with Bold New Ice Blended® Drink Menu and Refreshing Ube Coconut Lineup
The creators of the original Ice Blended® drink celebrate summer with nostalgic favorites, new modern flavors, and can't-miss, weekly promotions LOS ANGELES, June 6, 2025 /PRNewswire/ -- This summer, The Coffee Bean & Tea Leaf® is taking you on a flavor journey with a menu that blends nostalgia and innovation. Now through August 19, 2025, we're celebrating our legacy as the pioneers of the Ice Blended® drink, with a fresh lineup of drinks that's bound to become your new summer obsession. It all started in 1987, when a barista at Coffee Bean & Tea Leaf crafted the very first Ice Blended® drink, changing the world of coffee forever. Fast forward nearly four decades, and we're still leading the charge with that same spirit of creativity and passion. This summer, we're bringing back the classics—like the Ultimate Cold Brew Ice Blended® drink and CaraMocha Ice Blended® drink—and introducing bold new flavors that perfectly capture the essence of sunny California days. "We're thrilled to continue our legacy as tastemakers while constantly pushing the envelope with new and exciting flavor experiences," said Dee Hadley, Head of Marketing, Americas at The Coffee Bean & Tea Leaf. "We didn't just create the Ice Blended® drink, we started a movement. And now, we're inviting our guests to enjoy the flavors that made us who we are, alongside fresh, seasonal creations that are sure to make summer unforgettable." The summer lineup is all about celebrating the best of both worlds: the time-tested favorites that made us famous, and the bold new twists that keep things exciting. So, whether you're a long-time fan or new to the scene, there's something for everyone to savor. Get ready for a few surprises: The three new Ice Blended® beverages are a delicious mix of the classic and the contemporary, ensuring that each sip is as refreshing as a cool breeze on a hot Los Angeles day. Ready to experience summer in a cup? Head to your local cafe for the three new, bold Ice Blended beverages that build on Coffee Bean and Tea Leaf's legacy as a tastemaker of flavor innovation. The beverages include: Ultimate Cold Brew Ice Blended® Drink: Fan-favorite chocolate-covered espresso beans return in the new Ultimate Cold Brew Ice Blended® drink, delivering bold flavor and unbeatable texture. Finished with chocolate drizzle and whipped cream, it's the perfect caffeinated kick for summer. Want to take it up a notch? Make any drink Ultimate by adding chocolate-covered espresso beans. CaraMocha Ice Blended® Drink: A decadent remix of the beloved Mocha Ice Blended® drink, this version adds rich caramel blended in and drizzled throughout—a delightful evolution of a time-tested favorite. Pure CaraMocha Ice Blended® Drink: A twist on our popular Caramel Ice Blended, made with chocolate powder instead of vanilla for an indulgent, chocolatey sweet treat! Ube Coconut Affogato Ice Blended® Drink: Bright, tropical, and richly creamy, this seasonal sensation blends ube and coconut, crowned with a shot of espresso and a swirl of whipped cream. For those craving a lighter yet equally flavorful refreshment, Coffee Bean & Tea Leaf's new lineup of Ube Coconut beverages also includes the Iced Ube Coconut Cream Vanilla Latte with Boba, Iced Ube Coconut Cream Matcha Latte and Ube Coconut Cream Cap Modifier, for a tropical touch to any drink. To celebrate Coffee Bean & Tea Leaf's tastemaker history, the brand is rolling out exciting promotions all summer long: National Ice Blended Day (June 11): Guests can enjoy a $3 small Ice Blended® drink from 12–6 PM. Throwback Thursdays (June 19 - August 14): Every Thursday, from 12–6 PM, guests can grab a Regular Mocha or Vanilla Ice Blended® drink for just $4 (limit 2 per transaction; paid modifiers not included). Whether you're re-experiencing the Original Ice Blended® drink or trying a tropical twist for the first time, this summer is all about flavor, fun, and frozen memories at Coffee Bean & Tea Leaf. For more information about the new beverages, please visit About The Coffee Bean & Tea Leaf® Founded in Southern California in 1963, The Coffee Bean & Tea Leaf® is a global specialty coffee and tea house that inspires new experiences through our flavors from around the world. We source the finest coffees and teas from local communities and then handcraft every beverage to bring out the freshest flavors. As the creator of The Original Ice Blended®, we continue to innovate to enable people everywhere to enjoy the classics as well as new flavors both in our cafés and at home. Headquartered in Asia and a business of the Jollibee Group of Companies, The Coffee Bean & Tea Leaf passionately operates in more than 1,100 locations, across over 20 countries. For more information, visit View original content to download multimedia: SOURCE The Coffee Bean & Tea Leaf
Yahoo
4 hours ago
- Yahoo
LEADOPTIK Awarded Key Patents Across Three Continents
Strengthening Global IP Portfolio in Optical Imaging for Minimally Invasive Procedures SAN JOSE, Calif., June 6, 2025 /PRNewswire/ -- LEADOPTIK Inc., a Silicon Valley-based medical imaging company, today announced it has been awarded key patents for its proprietary optical probe across three continents: North America, Europe, and Asia. LEADOPTIK designs and manufactures optical probes for minimally invasive procedures, where two critical factors are essential: high-resolution imaging and a miniaturized form factor. High-resolution imaging enables real-time visualization of tissue microstructure, empowering clinicians with the insight needed to make more informed decisions—whether collecting biopsy samples, resecting tumor margins, or delivering therapies to targeted sites. Equally important is miniaturization. Space is at a premium during minimally invasive procedures, and LEADOPTIK's probe is designed with an exceptionally small footprint to navigate tight anatomical pathways without compromising performance. The company's innovation is powered by cutting-edge metasurface technology—flat optical components created through the fusion of nanofabrication and advanced optical design. Unlike traditional optics, metasurfaces enable ultra-thin, high-performance imaging systems that are ideal for integration into medical devices. These three newly granted patents underscore LEADOPTIK's leadership in medical imaging: U.S. Patent (#US11953698B1): Covers a novel device-level metasurface design that significantly extends imaging depth without sacrificing resolution. The patent was granted with 100% of its original claims—a testament to the novelty of LEADOPTIK's approach. European and Japanese Patents (PCT065237 & PCT029301): Protect both the current probe assembly method and alternative configurations that support expanded clinical applications. "Building robust and scalable medical devices is non-negotiable," said Reza Khorasaninejad, CEO and Co-founder of LEADOPTIK. "Our team has not only invented new optical designs but also developed novel methods of integrating them with semiconductor-grade manufacturing processes. These patents reflect our commitment to making next-generation imaging accessible, reliable, and globally protected." "Our intellectual property is the foundation of LEADOPTIK's competitive edge," said Dr. Jiang You, Co-Founder and VP of Medical Imaging. "These patents not only protect our unique optical architecture but also validate the deep technical innovation required to miniaturize high-resolution imaging. It's a major milestone that strengthens our ability to scale globally and expand into new clinical applications." About LEADOPTIK LEADOPTIK is a Silicon Valley-based company pioneering AI-enhanced real-time optical imaging at the point of biopsy. By integrating high-resolution microstructural visualization with emerging analytics, the LIA system bridges the gap between diagnosis, and therapy, supporting more precise and informed decision-making in interventional pulmonology and beyond. For more information, visit Media Contact:hello@ View original content: SOURCE LEADOPTIK Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
